An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease - Wikidata - wikimedia - TriplyDB

An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease

An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease

http://www.wikidata.org/entity/Q28581962

about

Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease Nutrition and AGE-ing: Focusing on Alzheimer's Disease.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.Sterile Neuroinflammation and Strategies for Therapeutic Intervention

P2860

Q35559895-D00B031E-DE74-4CD8-B5CE-A90F77B6C956 Q37607470-05406EF2-7F92-40B7-80CC-F757D421D630 Q38096444-4D76DC46-6C1E-47E2-BBE0-33035616BBB0 Q38136313-4B11CEAA-0183-4A35-840B-65F982FA850D Q38241689-F62E8FB9-590F-4AA2-921B-F848C978E0FB Q39105980-422E55F8-25A6-46DB-8C36-4BD4B0E322DE

P2860

An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease

http://www.wikidata.org/entity/Q28581962

description

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2012

@ast

im März 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2012/06/01)

@sk

vědecký článek publikovaný v roce 2012

@cs

wetenschappelijk artikel (gepubliceerd op 2012/06/01)

@nl

наукова стаття, опублікована в червні 2012

@uk

مقالة علمية (نشرت في يونيو 2012)

@ar

name

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@ast

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@en

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@nl

type

label

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@ast

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@en

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@nl

prefLabel

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@ast

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@en

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@nl

P1433

Q28581962-CE35EFC8-DF45-4C3B-877D-EBB56A7E48DA

P1476

Q28581962-4294BB95-310C-4B82-B766-03CE4F9E1581

P2093

Q28581962-0F161AE6-158A-442D-87DA-AA4BE8DAD2FD

Q28581962-615CBA47-DBAC-44D6-88A7-467F192564A4

Q28581962-C3AA6BA8-FC03-450C-870A-E89F9E931F64

Q28581962-F609D293-D9D5-45F1-B61D-83CE35EAE02D

P2860

Q28581962-0111009D-BCBE-42AA-A439-2BBAA7E12C92

Q28581962-02565377-DD64-4995-8E86-90830C769576

Q28581962-06500DE8-2FC2-48A5-8D1B-DB73D9970435

Q28581962-0A14D37D-0C15-471E-875F-F884B3DD5B83

Q28581962-16802247-9303-4FB6-A2CD-C546BD9CC572

Q28581962-178DBCCC-7261-4951-B5FE-C43411A08F98

Q28581962-190FEF90-7C78-4E36-B519-3175FA9F1015

Q28581962-1F1D9B2F-6E6D-4AC6-8F49-B8CD4102B671

Q28581962-2DE612F0-1ABE-4EF3-A095-F314177DBAF3

Q28581962-37189A57-F990-4A4D-A45A-7F54EFFE0B58

P2888

Q28581962-176CEC6C-A59B-4026-8BC3-281141F3DC7B

P304

Q28581962-3B152843-D9A7-4698-B1F7-C65D13C76746

P31

Q28581962-A3229C36-1067-4ABF-96EB-37B8E793AE29

P356

Q28581962-3AF0BB6A-2303-4331-BBC8-94F14904E81E

P433

Q28581962-6AAF8D48-8A1C-4712-9CF2-98564DC6644C

P478

Q28581962-EC38E3CE-0193-4FD3-BC81-B7CB8FCC2F01

P50

Q28581962-B887AAE1-1962-4A2A-ABA1-CFC64CA37873

P577

Q28581962-89E0CD4D-43DB-4E80-A018-8978F16EDA82

P5875

Q28581962-6C53735D-1469-4682-9A8B-48C0E361D6E4

P6179

Q28581962-3140647A-DF01-49C9-BADA-A115E7310695

P698

Q28581962-D75123F5-F41D-432D-A9D1-F9BE384BD502

P921

Q28581962-80C2006D-B591-40BC-938D-0BF67A9428C0

P356

S12017-012-8176-Z

P1433

NeuroMolecular Medicine

P1476

An aqueous orally active vacci ...... peutic for Alzheimer's disease

@en

P2093

Jerry J Buccafusco

http://www.w3.org/2001/XMLSchema#string

Scott J Webster

http://www.w3.org/2001/XMLSchema#string

Shyamala Mruthinti

http://www.w3.org/2001/XMLSchema#string

William David Hill

http://www.w3.org/2001/XMLSchema#string

P2860

Recent developments in Alzheimer's disease therapeutics

Forecasting the global burden of Alzheimer’s disease

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

Local neuroinflammation and the progression of Alzheimer's disease.

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.

P2888

s12017-012-8176-z

P304

119-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12017-012-8176-Z

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221893813

http://www.w3.org/2001/XMLSchema#string

P6179

1024111547

http://www.w3.org/2001/XMLSchema#string

P698

22415896

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease